We have a refreshed assay menu to help you better tackle infectious diseases
Explore QIAstat-Dx instruments
Make the right choice for your lab and get in touch today
QIAstat-Dx Analzyer and QIAstat-Dx Rise features
With the QIAstat-Dx family of analyzers, we have an instrument for every lab. Regardless of the configuration, all analyzers have modular options allowing for customization for your lab. And they all run assays using our preloaded cartridges and intuitive touchscreen display.
QIAstat-Dx Analyzer and QIAstat-Dx Rise specifications
Discover the assay menu
All QIAstat-Dx panels harness the power of our sleek cartridge design. This technology redefines ease-of use for multiplex testing by creating a workflow with less than one minute hands-on time.
- Save time – all reagents are preloaded into the cartridge
- Reduce errors and risk of contamination – tests are performed on a single instrument solution
- Lower costs – cartridges are shipped and stored at room temperature
Get connected with QIAsphere
*Some features require a QIAstat-Dx Connectivity plan. Flexible plans are available to meet your lab’s needs.
The QIAstat-Dx Analyzer, QIAstat-Dx Rise and QIAstat-Dx panels are intended for in vitro diagnostic use.
The QIAstat-Dx ME Panel is indicated as an aid in the diagnosis of specific agents that cause meningitis and/or encephalitis, and results must be used in conjunction with other clinical, epidemiological, and laboratory data. Results from the QIAstat-Dx ME Panel are not intended to be used as the sole basis for diagnosis, treatment, or other patient management decisions. Positive results do not rule out co-infection with organisms not included in the QIAstat-Dx ME Panel. The agent or agents detected may not be the definite cause of the disease. Negative results do not preclude central nervous system (CNS) infection.
The QIAstat-Dx ME Panel is intended for in vitro diagnostic use by laboratory professionals only.
Product availability may differ from country to country based on regulations and approvals. Contact your country representative for further details.